Dr. Elena L. Tsai, MD

Dr. Tsai practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Tsai's NPI, 1073601902, was assigned on October 10, 2006. Dr. Tsai graduated from UMass Chan Medical School in 2004. Dr. Tsai holds New York license 255821.

Dr. Tsai's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Tsai's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Tsai is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Tsai to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tsai practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Tsai's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Tsai is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Tsai's licenses on file in 2 states: New York and Massachusetts.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastrointestinal bleeding, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Tsai treats.

CMS data shows 402 Medicare services from Dr. Tsai across 9 procedure codes in 2024, for 213 Medicare patients. Medicare paid $69,964 for them.

CMS counts 213 Medicare patients who saw Dr. Tsai in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tsai's median patient age at 61, with 74% women.

In 2024, Dr. Tsai wrote 474 Medicare Part D claims for 219 patients. 84% of them were for generic drugs. CMS names the drug for 350 of them, across 7 drugs with 11 or more claims each, at $16,223 in total drug cost. In 2023, CMS named 239 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Tsai for performance year 2024, reported through an alternative payment model (APM). Dr. Tsai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tsai as offering telehealth. CMS counts 34 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Tsai, more than 57% of the clinicians it reports for that procedure.

CMS Open Payments shows 139 general payments to Dr. Tsai from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AOP Health US, LLC paid the most, $612.

Dmand AI lists 1 award for Dr. Tsai, most recently CMS Stage 1 EHR in 2012.

Dr. Tsai graduated from UMass Chan Medical School in 2004.

Dr. Tsai is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.